Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Onyda XR (clonidine hydrochloride) Non-Stimulant Liquid Treatment for ADHD
May 29, 2024 – Business Wire – Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity...
FDA Approves Bkemv (eculizumab-aeeb), an Interchangeable Biosimilar to Soliris
Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat...
Preeclampsia Linked to Increased Risk for Young-Onset Dementia
Individuals with preeclampsia have an increased risk for young-onset dementia, according to a research letter published online May 30 in JAMA Network Open.Valérie...
Binge Eating in Adults Improves Over Time, but Relapse Common
Binge-eating disorder (BED) does improve over time; however, remission often takes many years, according to a study published online May 28 in Psychological...
Racial Disparity Seen in Naloxone Administration
In Pennsylvania, from 2019 to 2021, Black people who died from overdose deaths had lower odds of naloxone administration compared with White and Hispanic...
Active Surveillance Effective Strategy for Favorable-Risk Prostate Cancer
Active surveillance is an effective management strategy for men with favorable-risk prostate cancer, with an estimated rate of metastasis of 1.4 percent...
Mediterranean Diet Cuts Women's Risk of Early Death by 23%
Experts have long extolled the benefits of the Mediterranean diet and a new study adds to that evidence, finding it cuts the odds for an early death in...
Almost 1 in 3 Americans Know Someone Who's Died From a Drug Overdose
As the opioid addiction crisis continues to lay waste to American life, a new survey finds that nearly a third of U.S. adults now know someone who's died...
1 in 8 Older Americans Are Stricken With Traumatic Head Injury
About one in eight U.S. seniors will be treated for a traumatic brain injury, typically during a fall, a new study finds. Medicare data shows that about...
Could Tough Workouts Trigger a Hot Flash?
While going through menopause, many women who gain weight head to the gym for intense workouts, but new research suggests that too much exercise may help...
Avirmax Biopharma Inc. Receives IND Approval for Phase I/IIa Trial to Treat Wet AMD including PCV
HAYWARD, Calif., May 30, 2024. Avirmax Biopharma, Inc., a leading innovator in genetic medicines, is pleased to announce that it has received Investigational...
CG Pharmaceuticals Prepares to Showcase Its Ongoing Phase 2 Study for Ivaltinostat in Metastatic Pancreatic Ductal Adenocarcinoma
ORINDA, Calif., May 29, 2024. CG Pharmaceuticals, a company dedicated to advancing innovative therapies to improve the lives of patients with cancer, prepares...
Could Tattoos Be Linked to Blood Cancer Risk?
Research suggests that tattoo ink spurs inflammatory changes that might contribute to the development of lymphoma. The findings are early, however, and...
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to Potential Presence of Particulate Matter
SCHAUMBURG, IL – May 28, 2024 – Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection,...
Recently Added
Recently added consumer and prescribing information: Bkemv, Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Onyda XR Onyda XR is a once-daily extended-release oral suspension of clonidine hydrochloride for the treatment of attention-deficit/hyperactivity...
- Bkemv Bkemv (eculizumab-aeeb) is a complement inhibitor interchangeable biosimilar to Soliris for the treatment of paroxysmal nocturnal...
- Yesafili Yesafili (aflibercept-jbvf) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...